mirtazapine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Di Pauli, F | 1 |
Berger, T | 1 |
Walder, A | 1 |
Maier, H | 1 |
Rhomberg, P | 1 |
Uprimny, C | 1 |
Steurer, M | 1 |
Stockhammer, G | 1 |
Lutz, M | 1 |
Schulze, AB | 1 |
Rebber, E | 1 |
Wiebe, S | 1 |
Zoubi, T | 1 |
Grauer, OM | 1 |
Keßler, T | 1 |
Kerkhoff, A | 1 |
Lenz, G | 1 |
Berdel, WE | 1 |
2 other studies available for mirtazapine and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: case report and review of the literature.
Topics: Cytarabine; Disease Progression; Female; Humans; JC Virus; Leukemia, Lymphocytic, Chronic, B-Cell; L | 2014 |
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia.
Topics: Adenine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Disease | 2017 |